Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Tachycardia

• Using Mirabegron to Increase BP in Patients With POTS
• Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy
• Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation
• Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
• Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
• A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
• imPROving Quality of LIFe In the Long COVID Patient
• The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
• Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
• Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
• Dexmedetomidine and Magnesium Sulfate in Preventing Junctional Ectopic Tachycardia After Pediatric Cardiac Surgery
• Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
• Venous Ethanol for Ventricular Tachycardia
• Ivabradine for Long-haul COVID With POTS Cohort
• Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
• Effects of Heart Control at Different Stages in Patients of Septic Shock With Tachycardia
• Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
• Low Dose Naltrexone Use in Patients With POTS
• Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia
• Treatment of an Inherited Ventricular Arrhythmia
• Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study
• Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia
• Compression Garments in the Community With POTS
• Iron Sucrose in Patients With Iron Deficiency and POTS
• Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility
• Comparison of Ventricular Tachycardia Ablation Strategies in Patients With Ischemic Cardiomyopathy
• A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)
• Gabapentin Treatment of Postural Tachycardia Syndrome (PoTS)
• Treatment of Supraventricular Tachycardia in Patients With Non-cardiac Surgery by Dexmedetomidine
• Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation
• Adenosine Versus Verapamil for Management of Supraventricular Tachycardia Post- Coronary Artery Bypass Grafting
• Crossover Study of Propranolol vs Ivabradine in POTS
• Autonomic Determinants of POTS - Pilot 2
• A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.
• Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
• Autonomic Determinants of POTS - Pilot1
• IVIG (Gamunex-C) Treatment Study for POTS Subjects
• Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.
• Epinephrine Dose: Optimal Versus Standard Evaluation Trial
• Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia
• The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
• Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
• Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract
• Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE 301 [Part 1 and Part 2 (The RAPID Study)]
• Dexmedetomidine and Fentanyl Versus Midazolam and Remifentanil for Sedation in Patients Undergoing Ablation Procedures
• Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions
• Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine
• A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS
• Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS
• Contrast ICE for Myocardial Scar in VT Ablations
• Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome
• Vagal Stimulation in POTS
• Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
• Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
• Antiarrhythmics or Ablation for Ventricular Tachycardia 2
• Autoimmune Basis for Postural Tachycardia Syndrome
• POTS Adrenergic Ab (CIHR Aims #1&2)
• DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation
• Prospective Randomized Clinical Trial for Effect of Stellate Ganglion Block in Medically Refractory Ventricular Tachycardia
• Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)
• Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)
• Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia
• Esmolol to Treat the Hemodynamic Effects of Septic Shock
• Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias
• INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events
• Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm
• Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients
• Echocardiographic and Arterial Pressure Waveform Changes After Reducing Heart Rate With Esmolol in Septic Shock Patients
• Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
• Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
• A Study of Caffeine on Cardiac Arrhythmias
• Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias
• Botulinum Toxin Injection to Prevent Ventricular Arrhythmias
• Modafinil and Cognitive Function in POTS
• Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)
• Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia
• Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
• Effect of Desmopressin on Platelet Function in CKD Patients on Antiplatelet Drug
• Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia
• Mechanisms of Vasovagal Syncope
• Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias
• Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)
• The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome
• Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
• Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia
• Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control
• A Comparison of the Perioperative Hemodynamic Effects of Remifentanil and Esmolol in Intracranial Surgery
• Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
• Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator
• Safety of Amiodarone and Ranolazine Together in Patients With Angina
• Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
• Dexmedetomidine and Adenosine: Therapeutic Use for SVT
• Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
• Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea
• Ivabradine in Hemodialysed Patients With Increased Heart Rate
• The Effect of Dexmedetomidine on Hemodynamic Response During Double Lumen Endotracheal Intubation
• Study Evaluating the Efficacy and Safety of Remifentanil in a Rapid Sequence Induction for Fragile Subjects
• Imaging With a Radio Tracer to Guide VT Ablations
• Local Vasoconstriction in Postural Tachycardia Syndrome
• Esmolol for Treatment of Perioperative Tachycardia
• Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
• Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
• Intranasal Injection Versus Topical Administration of Epinephrin During Endoscopic Sinus Surgery
• Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
• Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
• The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
• Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy
• Cardiovascular Effects of Selective I(f)-Channel Blockade
• Effect of Exercise in OI
• Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation
• Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia
• Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
• Intravenous Beta-blockade for Improvement of Autonomic Activity
• Peripheral Dopamine in Postural Tachycardia Syndrome
• Pathophysiology of Orthostatic Intolerance
• Clonidine to Prevent Implantable Cardiovertor Defibrillator Firing
• Autonomic Nervous System and Chronic Fatigue Syndrome
• Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker
• Exteriorized Versus In Situ Uterine Repair at Cesarean Delivery
• Effectiveness of Calcium Channel Blockers and Adenosine in the Emergency Management of SVT
• A Study of Pyridostigmine in Postural Tachycardia Syndrome
• Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
• Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia
• Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia
• Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
• Treatment of Orthostatic Intolerance
• Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)
• Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS
• Processing and Effects of Cannabis
• Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan
• Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan
• Study Evaluating GAP-486 in Non-Sustained Ventricular Tachycardia
• Antiarrhythmics Versus Implantable Defibrillators (AVID)
• Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
• Multicenter Unsustained Tachycardia Trial (MUSTT)